About 3 100 reports

Serbia Pharmaceuticals and Healthcare Report Q2 2015

108 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: A demand for austerity measures and public sector cuts by the IMF and the ongoing privatisation of state-owned enterprises will push the Serbian government to reduce its fiscal expenditure. The national health insurance fund will be pressured into reining in its costs, and...

985 1 300 818
Apr 2015

Greece Pharmaceuticals and Healthcare Report Q2 2015

100 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Since the election of the Syriza party in early 2015, Greece has seen considerable escalation in both political and economic uncertainty. This will limit the implementation of reform in the health sector and exacerbate the already high operational risks borne by drugmakers....

985 1 300 818
Apr 2015

Norway Pharmaceuticals and Healthcare Report Q2 2015

66 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Norway's epidemiological profile will continue to be attractive to manufacturers of medicines for non-communicable diseases. Despite the relative rapid uptake of innovative pharmaceuticals, the burden of chronic conditions will only decrease slightly over the next 15 years....

985 1 300 818
Apr 2015

Italy Pharmaceuticals and Healthcare Report Q2 2015

96 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: SNS pharmaceutical expenditure will decline in 2015 - creating revenue pressures for drugmakers and pharmacies in Italy and increasing out-of-pocket costs for the population. In February 2015, it was announced that the public healthcare costs will be slashed by EUR2.6bn (USD2.9bn)...

985 1 300 818
Apr 2015

Iraq Pharmaceuticals and Healthcare Report Q2 2015

83 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Iraq's attractiveness as a pharmaceutical market is highly dependent on the security situation in the country. With the Islamic State (IS) negatively impacting healthcare access in the northern states, Iraq's pharmaceutical market appeal to foreign investors has weakened....

985 1 300 818
Apr 2015

Ghana Pharmaceuticals and Healthcare Report Q2 2015

122 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Our outlook for Ghana's pharmaceutical and healthcare market is becoming increasingly bearish. The National Health Insurance Scheme is facing backlash from both drugmakers and service providers due to a lack of payments. Furthermore, we believe that the scheme will come under...

985 1 300 818
Apr 2015

Thailand Medical Tourist Arrivals and Spending Forecast To 2020

76 pages • By Igate Research

Thailand Medical Tourism Market – OverviewThailand has gained recognition as a credible medical tourism destination. Thailand’s medical tourism industry continues to grow at an impressive rate primarily due to its expanding network of medical facilities catering to international visitors and proactive marketing by tourism officials....

720 900 576
Apr 2015

Adult Mouth Care in Bulgaria

23 pages • By Euromonitor International

In 2014, adult mouth care achieves 2% growth in current value sales to reach BGN3.7 million. Despite significant presence of health conditions, Bulgarian consumers reach after specialized adult mouth care products less frequently which results in positive, yet very modest growth of the category.Euromonitor International's Adult Mouth...

675 898 601
Apr 2015

Sopharma AD in Consumer Health (Bulgaria)

3 pages • By Euromonitor International

Sopharma AD is Bulgaria’s largest pharmaceuticals manufacturer and the second leading company within consumer health in Bulgaria. The company’s main objectives are to retain its leading position and to further grow and develop its core business. In order to maintain the highest possible quality of its products and be in line with market trends,...

115 153 102
Apr 2015

Calming and Sleeping in Bulgaria

20 pages • By Euromonitor International

In 2014, calming and sleeping in Bulgaria achieves 7% current value growth reaching sales of BGN6.1 million. Increased popularity of calming and sleeping products is due to their effects in alleviating symptoms of stress and fatigue from the increasingly busy lives of the average Bulgarian consumer which has contributed to the category growth.Euromonitor...

675 898 601
Apr 2015

NRT Smoking Cessation Aids in Bulgaria

18 pages • By Euromonitor International

In 2014, NRT smoking cessation aids achieves 9% growth in current value terms to reach sales of BGN1.9 million. Increased rate of quitting smoking and the declining smoking prevalence rate work in favour of the development of the NRT smoking cessation aids market and thus resulting in significant and strong value growth in 2014.Euromonitor...

675 898 601
Apr 2015

Consumer Health in Bulgaria

104 pages • By Euromonitor International

The Bulgarian consumer health market remained in good health in 2014 as many of its categories, particularly digestive remedies, calming and sleeping, dermatologicals, cough, cold and allergy (hay fever) remedies and vitamins and dietary supplements, posted solid growth rates. Although 2014 did not see a large number of significant new product...

1 800 2 394 1 602
Apr 2015

Digestive Remedies in Bulgaria

25 pages • By Euromonitor International

In 2014, digestive remedies achieves 5% current value growth reaching total sales of BGN20 million. Poor eating habits and nutritional choices are largely responsible for the increase in use of digestive remedies and represent the main engines of value growth for the category.Euromonitor International's Digestive Remedies in Bulgaria...

675 898 601
Apr 2015

Apteki Remedium EOOD in Consumer Health (Bulgaria)

2 pages • By Euromonitor International

Formerly known as ET Terrachim – Nikolay Kostov, Apteki Remedium EOOD is the owner and operator of one of the most popular chains of pharmacies in Bulgaria, Remedium. This chain has become one of the most successful in the country, despite only being concentrated in the capital city of Sofia, and that to date it consists of just nine pharmacies....

115 153 102
Apr 2015

Borola EOOD in Consumer Health (Bulgaria)

3 pages • By Euromonitor International

Borola EOOD is currently primarily present in the weight management and several other categories of the Bulgarian consumer health market. The company’s strategic goal is to achieve the leading positions in the said categories, particularly in weight management. The categories in which it is present include the production of dermatologicals...

115 153 102
Apr 2015

Wound Care in Bulgaria

17 pages • By Euromonitor International

In 2014, wound care experienced 3% current value growth to reach sales of BGN4.7 million. The category is rapidly approaching maturity as the market is becoming fairly saturated with wound care products with little innovation and no new application formats available for sale on the market due to their high unit prices.Euromonitor International's...

675 898 601
Apr 2015

Weight Management in Bulgaria

21 pages • By Euromonitor International

In 2014, weight management achieved 8% current value sales growth, reaching sales of BGN25 million with weight loss supplements remaining the key largest weight management range, accounting for 53% of total category sales.Euromonitor International's Weight Management in Bulgaria report offers a comprehensive guide to the size and shape...

675 898 601
Apr 2015

Actavis EAD in Consumer Health (Bulgaria)

3 pages • By Euromonitor International

Actavis EAD is the leading consumer health company in Bulgaria, responsible for sales and marketing activities in the country and manufacturing in its own facilities in the Bulgarian towns of Dupnitsa and Troyan. The company has built upon the experience of former company Balkanpharma, which had been present in the country for over 50 years....

115 153 102
Apr 2015

Analgesics in Bulgaria

25 pages • By Euromonitor International

Analgesics achieves modest 2% current value growth in 2014, reaching BGN123 million. Adult aspirin and adult dipyrone are the pillars of the analgesics category, together accounting for a combined value share of 49% in 2014. The flu season was not as bad as in previous years, although an increased incidence in the use of painkillers to treat...

675 898 601
Apr 2015

Dermatologicals in Bulgaria

29 pages • By Euromonitor International

Falling victim to beauty and personal care, particularly skin care and hair care, dermatologicals in Bulgaria is yet to start developing as it is a young and fairly underdeveloped category. In 2014, dermatologicals achieves 4% growth to reach sales of BGN21 million. Medicated shampoos remains the single largest dermatologicals category accounting...

675 898 601
Apr 2015

Herbal/Traditional Products in Bulgaria

26 pages • By Euromonitor International

Sales of herbal/traditional products continued to increase steadily over most of the review period to reach BGN38 million in 2014. Underdevelopment and a low base are the two major reasons for the rapid growth of the category, including the ever-increasing popularity of dietary supplement products over the review period.Euromonitor...

675 898 601
Apr 2015

Eye Care in Bulgaria

17 pages • By Euromonitor International

In 2014 eye care registered 4% growth reaching current value sales of BGN2.9 million Increased volume demand to treat both red eye and allergy eye is the main contributing factor to the mild growth of eye care in Bulgaria in 2014.Euromonitor International's Eye Care in Bulgaria report offers a comprehensive guide to the size and shape...

675 898 601
Apr 2015

Cough, Cold and Allergy (Hay Fever) Remedies in Bulgaria

27 pages • By Euromonitor International

In 2014, cough, cold and allergy (hay fever) remedies achieves 3% current value growth reaching sales of BGN66 million. Despite the prolonged allergy season, moderate flu and cold seasons of 2014, coupled with current demographics could only contribute to a mild current value growth in 2014.Euromonitor International's Cough, Cold and...

675 898 601
Apr 2015

Cambodia and Laos Pharmaceuticals and Healthcare Report Q2 2015

80 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Despite Cambodia's aim towards universal health coverage, we highlight that financial sustainability will remain a key issue. Nevertheless we highlight that pharmaceutical firms will benefit from this.Headline Expenditure Projections- Pharmaceuticals: KHR910.8bn...

985 1 300 818
Apr 2015

Australia Pharmaceuticals and Healthcare Report Q2 2015

144 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Recent attempts by the Australian government to introduce cost saving changes to the Medicare program have been met with opposition. Most have now been shelved. With healthcare costs growing at a 'rapid and unsustainable rate', as reported by Health Minister Sussan Ley, the government...

985 1 300 818
Apr 2015

Indonesia Pharmaceuticals and Healthcare Report Q2 2015

148 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Generic drugs sales in Indonesia will continue to see significant growth as they remain favoured by both low per capita pharmaceutical spending and inadequate intellectual property protection in the country. This is further reinforced by a growing chronic disease burden led by cardiovascular...

985 1 300 818
Apr 2015

Venezuela Pharmaceuticals and Healthcare Report Q2 2015

119 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Venezuela's pursuit of autonomy in pharmaceutical production and its overall pharmaceutical market will continue to diminish its appeal for foreign drugmakers. As the country deals with one of the worst performing currencies in the world, multinational pharmaceutical companies will...

985 1 300 818
Apr 2015

India Pharmaceuticals and Healthcare Report Q2 2015

165 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: India's challenging intellectual property landscape will continue to drive innovative drugmakers to adopt risk mitigation strategies, including forming partnerships with Indian generic pharmaceuticals companies. We highlight that such collaborations will also boost the marketing efforts...

985 1 300 818
Apr 2015

Lithuania Pharmaceuticals and Healthcare Report Q2 2015

100 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The deteriorating macro outlook for Russia will impact Lithuania's economy, with negative effects on fiscal planning and therefore the pharmaceutical and healthcare sectors. However, the centre-left government's partial reversal of austerity measures, raising of minimum wages and boosts...

985 1 300 818
Apr 2015

Kuwait Pharmaceuticals and Healthcare Report Q2 2015

108 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: While the persistence of lower oil prices will drive down national budgets and curtail some investment programmes, we maintain that the healthcare sector's perception as a critical source of economic diversification away from hydrocarbons in addition to public support, will continue...

985 1 300 818
Apr 2015